Overview
Fan Zhou practices in Nanjing, China. Ms. Zhou is rated as an Experienced expert by MediFind in the treatment of Gallbladder Cancer. Her top areas of expertise are Multiple Myeloma, Coronary Heart Disease, Congenital Coronary Artery Malformation, Hepato-Pancreato-Biliary Surgery, and Endoscopy.
Her clinical research consists of co-authoring 309 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Gallbladder Cancer.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Congenital Coronary Artery Malformation
- Coronary Heart DiseaseMs. Zhou isAdvanced. Learn about Coronary Heart Disease.
- Lung AdenocarcinomaMs. Zhou isAdvanced. Learn about Lung Adenocarcinoma.
- Multiple MyelomaMs. Zhou isAdvanced. Learn about Multiple Myeloma.
- Experienced
- Abdominal Obesity Metabolic Syndrome
- Acute Coronary SyndromeMs. Zhou isExperienced. Learn about Acute Coronary Syndrome.
- Acute Myeloid Leukemia (AML)Ms. Zhou isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adenoid Cystic CarcinomaMs. Zhou isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Immune ThrombocytopeniaMs. Zhou isExperienced. Learn about Adult Immune Thrombocytopenia.
- AnginaMs. Zhou isExperienced. Learn about Angina.